Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (1-10 of 304) with videos related to

Pageof 31
Sort By:
European Heart Journal. Acute Cardiovascular Care|March 15, 2021
European Heart Journal - Acute Cardiovascular Care moving onwards and upwardsPascal Vranckx
European Heart Journal. Acute Cardiovascular Care|September 7, 2023
MULTi-vessel Immediate vs. STAged RevaScularization in Acute Myocardial Infarction: the MULTISTARS AMI trialXavier Rossello, Pascal Vranckx
European Heart Journal. Acute Cardiovascular Care|April 10, 2024
Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trialPascal Vranckx, Marco Valgimigli
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 22, 2020
Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulantsAndreas Goette, Pascal Vranckx
European Heart Journal. Acute Cardiovascular Care|April 2, 2025
Cracking the clot: the RIVAWAR trial challenges warfarin's reign in left ventricular thrombus post-acute coronary syndromePascal Vranckx, Sigrun Halvorsen
Circulation|October 24, 2012
Letter by Vranckx and Valgimigli regarding article, "validation of the bleeding academic research consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention"Pascal Vranckx, Marco Valgimigli
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2022
Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!Pascal Vranckx, Marco Valgimigli
European Heart Journal. Acute Cardiovascular Care|March 10, 2023
BIOVASC trial in perspective: complete revascularization strategies in patients presenting with acute coronary syndromes and multi-vessel coronary diseasePascal Vranckx, Sean van Diepen
European Heart Journal. Acute Cardiovascular Care|September 19, 2025
The NEO-MINDSET trial: immediate aspirin withdrawal after percutaneous coronary intervention for acute coronary syndrome-remains a therapeutic no-man's landPascal Vranckx, Marin Pavlov, Sigrun Halvorsen
European Heart Journal. Acute Cardiovascular Care|March 15, 2022
Appointment as patient advocacy associate editorPascal Vranckx, David Morrow, Frederik Verbrugge
Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
European Heart Journal. Acute Cardiovascular Care|March 15, 2021
European Heart Journal - Acute Cardiovascular Care moving onwards and upwardsPascal Vranckx
European Heart Journal. Acute Cardiovascular Care|September 7, 2023
MULTi-vessel Immediate vs. STAged RevaScularization in Acute Myocardial Infarction: the MULTISTARS AMI trialXavier Rossello, Pascal Vranckx
European Heart Journal. Acute Cardiovascular Care|April 10, 2024
Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trialPascal Vranckx, Marco Valgimigli
European Heart Journal Supplements : Journal of the European Society of Cardiology|October 22, 2020
Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulantsAndreas Goette, Pascal Vranckx
European Heart Journal. Acute Cardiovascular Care|April 2, 2025
Cracking the clot: the RIVAWAR trial challenges warfarin's reign in left ventricular thrombus post-acute coronary syndromePascal Vranckx, Sigrun Halvorsen
Circulation|October 24, 2012
Letter by Vranckx and Valgimigli regarding article, "validation of the bleeding academic research consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention"Pascal Vranckx, Marco Valgimigli
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 22, 2022
Antithrombotic therapy in patients with atrial fibrillation undergoing PCI remains a moving target, yet with a clearer direction!Pascal Vranckx, Marco Valgimigli
European Heart Journal. Acute Cardiovascular Care|March 10, 2023
BIOVASC trial in perspective: complete revascularization strategies in patients presenting with acute coronary syndromes and multi-vessel coronary diseasePascal Vranckx, Sean van Diepen
European Heart Journal. Acute Cardiovascular Care|September 19, 2025
The NEO-MINDSET trial: immediate aspirin withdrawal after percutaneous coronary intervention for acute coronary syndrome-remains a therapeutic no-man's landPascal Vranckx, Marin Pavlov, Sigrun Halvorsen
European Heart Journal. Acute Cardiovascular Care|March 15, 2022
Appointment as patient advocacy associate editorPascal Vranckx, David Morrow, Frederik Verbrugge
Pageof 31